UiPath (PATH) is trading lower on April 10, 2026, with the decline tied to continued post-guidance pressure and renewed analyst skepticism about how quickly growth can re-accelerate. In recent days, at least one major brokerage reduced its price target while keeping a Neutral stance, explicitly pointing to mid-single to high-single-digit growth expectations and the need for clearer proof that net-new ARR trends are improving.

The stock’s pullback comes as the market continues to weigh UiPath’s transition narrative—profitability progress and “agentic automation” positioning—against signs that top-line expansion is settling into slower territory. Analyst commentary has focused on whether UiPath can translate AI/agentic product momentum into sustained net-new ARR growth and faster revenue growth, rather than primarily margin-driven upside.

Options activity has remained elevated around PATH in the days leading into April 10, which can amplify day-to-day volatility when the stock is already under pressure. With the shares well below prior highs and investors split between valuation support and growth skepticism, incremental negative research updates can have an outsized impact on daily price action.

Near-term direction is likely to hinge on signs that constant-currency net-new ARR is improving, enterprise deal cycles are not lengthening further, and management’s fiscal 2027 framework is achievable without sacrificing competitive positioning. Any additional analyst downgrades or price-target cuts could keep the stock pinned, while evidence of stronger AI monetization or improving ARR momentum would be the clearest counter-catalyst.